Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MITRA.BR
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Mithra Pharmaceuticals SA
- Exchange
- (BR ,
- Currency
- EUR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 14.45M
- Ent value
- 395.28M
- Price/Sales
- 0.15
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 49.32%
- 1 year return
- -89.62%
- 3 year return
- -77.14%
- 5 year return
- -61.78%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
MITRA.BR does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.15 |
| Price to Book | - |
| EV to Sales | 4.13 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 66.91M |
| EPS (TTM) | -2.92 |
| FCF per share (TTM) | -0.62 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 95.79M |
| Gross profit (TTM) | 42.98M |
| Operating income (TTM) | -71.79M |
| Net income (TTM) | -201.88M |
| EPS (TTM) | -2.92 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 44.86% |
| Operating margin (TTM) | -74.94% |
| Profit margin (TTM) | -210.74% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 8.98M |
| Net receivables | 36.09M |
| Total current assets | 93.41M |
| Goodwill | 5.23M |
| Intangible assets | 108.71M |
| Property, plant and equipment | 0.00 |
| Total assets | 286.55M |
| Accounts payable | 59.07M |
| Short/Current long term debt | 205.86M |
| Total current liabilities | 103.98M |
| Total liabilities | 389.80M |
| Shareholder's equity | -103.26M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -23.73M |
| Capital expenditures (TTM) | 19.42M |
| Free cash flow (TTM) | -43.15M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -70.45% |
| Return on Invested Capital | 263.70% |
| Cash Return on Invested Capital | 56.36% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| MITRA.BR | S&P500 | |
| Current price drop from All-time high | -99.42% | - |
| Highest price drop | -99.46% | -56.47% |
| Date of highest drop | 15 Mar 2024 | 9 Mar 2009 |
| Avg drop from high | -45.73% | -11.07% |
| Avg time to new high | 79 days | 12 days |
| Max time to new high | 1625 days | 1805 days |
COMPANY DETAILS
Marketcap
14.45M
Marketcap category
Small-cap
Description
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Belgium
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that in the context of the monetization process and the uncertainti...
May 28, 2024
Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of several binding offers, Mithra ha...
May 3, 2024
Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure full re...
April 29, 2024
Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing Organization.Approv...
April 22, 2024